I. Jagne

Maternal pneumococcal nasopharyngeal carriage and risk factors for neonatal carriage after the introduction of pneumococcal conjugate vaccines in The Gambia.

U. d’Alessandro, A. Roca, C. Bottomley, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Impact of intra-partum azithromycin on carriage of group A streptococcus in the Gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial

A. Roca, C. Bottomley, T. D. de Silva, 2020, BMC Infectious Diseases.

Effect of Intrapartum Azithromycin vs Placebo on Neonatal Sepsis and Death: A Randomized Clinical Trial.

H. Tinto, C. Bottomley, T. Rouamba, 2023, JAMA.

Pre-delivery administration of azithromycin to prevent neonatal sepsis and death: a phase iii double-blind randomized clinical trial (PregnAnZI-2 trial)

H. Tinto, C. Bottomley, T. Rouamba, 2022, International Journal of Clinical Trials.

A systematic review of pneumococcal conjugate vaccine impact on pneumococcal nasopharyngeal colonisation density in children under 5 years of age.

B. Ortika, Fiona M Russell, C. von Mollendorf, 2023, Vaccine.